Mesothelioma Treatment by State

It can take up to 50 years to develop mesothelioma after asbestos exposure, which means there are thousands of people across the United States being diagnosed each year who need treatment. These patients can find help from specialized doctors at top cancer centers and hospitals throughout the nation. Learn more about mesothelioma treatment by state below.

Written and Fact-Checked by: Laura Wright

How Do I Find Mesothelioma Treatment Near Me?

If you’ve been diagnosed with mesothelioma, you and your family may be wondering where you can get the best treatment. Fortunately, there are many cancer centers across the country with doctors who specialize in mesothelioma. These doctors can develop a custom treatment plan based on your individual needs and diagnosis.

Your treatment plan may include a combination of chemotherapy, surgery, and other therapies. You may also be able to access new treatments through clinical trials.

The first step to receiving the right treatment is to make an appointment with a mesothelioma specialist.

We can help you connect with local mesothelioma doctors regardless of where you live. Try our Free Doctor Match now.

Mesothelioma doctor talking with an older couple
Free Mesothelioma Doctor Match

We'll help you connect with a local mesothelioma specialist for personalized treatment.

Find a Doctor Near You

Top States for Mesothelioma Treatment

From Moffitt Cancer Center in Tampa to UCLA Medical Center in Los Angeles, there are a number of mesothelioma treatment centers across the country that can provide patients with specialized cancer care.

Some of the best mesothelioma cancer centers are located in:

If you or a loved one is researching mesothelioma cancer centers, try looking for hospitals that have been recognized by the National Cancer Institute (NCI). This indicates that the facility has met strict criteria for conducting advanced cancer research aimed at finding better ways to prevent, diagnose, and treat mesothelioma.

All of the states listed above are home to at least one NCI-designated cancer center.

Mesothelioma Treatment Options

Pursuing treatment at a mesothelioma center is critical to improving your overall prognosis and life expectancy.

Did You Know?

Pleural mesothelioma patients who receive standard treatments have higher survival rates than patients who go untreated, according to a 2023 report published in the journal Cancer Medicine.

Standard mesothelioma treatment options include:

  • Surgery: Malignant mesothelioma patients may be eligible for tumor-removing surgeries as well as minor outpatient procedures that can help relieve swelling, chest pain, and other painful symptoms.
  • Chemotherapy: Powerful chemotherapy medications administered orally or intravenously target and kill mesothelioma cancer cells throughout the body.
  • Radiation therapy: High-energy radiation is delivered directly to areas with mesothelioma tumors, destroying cancer cells while minimizing damage to healthy tissues.

Mesothelioma cancer centers also offer emerging treatments such as immunotherapy that are being tested in clinical trials and showing improvements in overall survival for some mesothelioma patients. Immunotherapy drugs work by activating the body’s immune response to target and destroy cancer cells.

A 2021 clinical trial led by researchers at MD Anderson Cancer Center found that 40% of peritoneal mesothelioma patients achieved complete or partial remission after being treated with the immunotherapy medications atezolizumab (TECENTRIQ®) and bevacizumab (Avastin®).

Make sure to ask your specialist which treatment options are best for your stage and type of mesothelioma. Download our Free Checklist of Questions to Ask Your Doctor before your next appointment so you leave with the answers you need.

14 Questions to Ask Your Doctor packet
Free Download: 14 Questions to Ask Your Doctor
  • Preparing for treatment
  • Finding clinical trials
  • Getting a second opinion

Get Your Free Download

Locate Mesothelioma Clinical Trials Near You

Clinical trials for mesothelioma are available in some states. Mesothelioma Hope maintains an up-to-date list of ongoing clinical trials categorized by location.

Use our search tool below to see if there are any active mesothelioma clinical trials in your area and get help enrolling.

Active Mesothelioma Clinical Trials (83)Show trials only in:
Clinical Trial for Clear Cell Renal Cell Carcinoma from CRISPR Therapeutics
Location: Nashville, Tennessee
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Clear Cell Renal Cell Carcinoma from CRISPR Therapeutics

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
A Phase 1/2, Open-label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With Relapsed or Refractory Solid Tumors

Conditions
  • Malignant Pleural Mesothelioma
Interventions
  • Biological: CTX131
Facility
  • Research Site 1, Nashville, Tennessee
Clinical Trial for Malignant Pleural Mesothelioma (MPM) from Memorial Sloan Kettering Cancer Center
Location: New York, New York
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Malignant Pleural Mesothelioma (MPM) from Memorial Sloan Kettering Cancer Center

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
A Single-Arm, Open-Label, Phase I Trial to Assess the Safety of Genetically Engineered Autologous T Cells Targeting the Cell Surface Antigen Mesothelin With Cell-Intrinsic Checkpoint Inhibition in Patients With Mesothelioma

Conditions
  • Malignant Pleural Mesothelioma (MPM)
Interventions
  • Drug: cyclophosphamide
  • Biological: CAR T cells
Facility
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
Clinical Trial for Gastric Cancer from University of Pittsburgh
Location: Pittsburgh, Pennsylvania
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Gastric Cancer from University of Pittsburgh

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers

Conditions
  • Mesothelioma
Interventions
  • Biological: Tumor Infiltrating Lymphocytes (TIL)
  • Drug: Fludarabine + Cyclophosphamide combination
Facility
  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)
Location: Bethesda, Maryland
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
Phase I Study of Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma

Conditions
  • Mesothelioma
Interventions
  • Biological: LMB-100
  • Drug: ipilimumab
Facility
  • National Institutes of Health Clinical Center, Bethesda, Maryland
Clinical Trial for Mesothelioma from Brigham and Women's Hospital
Location: Boston, Massachusetts
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Mesothelioma from Brigham and Women's Hospital

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
MAGIC-AKI: Magnesium for the Prevention of Hyperthermic Intraoperative Cisplatin-Associated AKI

Conditions
  • Mesothelioma
Interventions
  • Drug: Magnesium sulfate
Facility
  • Brigham and Women's Hospital, Boston, Massachusetts
Clinical Trial for Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center
Location: Houston, Texas
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
Ex-Vivo Expanded Allogeneic NK Cells for the Treatment of Solid Tumors of Pediatric Origin in Children and Young Adults

Conditions
  • Recurrent Malignant Mesothelioma
  • Refractory Malignant Mesothelioma
Interventions
  • Biological: Cord Blood-derived Expanded Allogeneic Natural Killer Cells
  • Drug: Cyclophosphamide
  • Drug: Etoposide
Facility
  • M D Anderson Cancer Center, Houston, Texas
Clinical Trial for Solid Tumors, Adult from Ikena Oncology
Location: Boston, Massachusetts (multiple locations)
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Solid Tumors, Adult from Ikena Oncology

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
A Phase 1, First-in-Human Study of IK-930, an Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors

Conditions
  • Mesothelioma (MPM)
Interventions
  • Drug: IK-930
Facility
  • Massachusetts General Hospital, Boston, Massachusetts
  • Start Midwest, Grand Rapids, Michigan
  • Memorial Sloan Kettering Cancer Center, New York, New York
  • Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
  • Sarah Cannon Research Institute, Nashville, Tennessee
  • MD Anderson Cancer Center, Houston, Texas
  • Next Oncology, San Antonio, Texas
Clinical Trial for Mesothelioma from TCR2 Therapeutics
Location: San Francisco, California (multiple locations)
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Mesothelioma from TCR2 Therapeutics

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
A Phase 1/2 Single Arm Open-Label Clinical Trial of Gavocabtagene Autoleucel (Gavo-cel) in Patients With Advanced Mesothelin-Expressing Cancer

Conditions
  • Mesothelioma
  • Mesothelioma, Malignant
  • Mesothelioma; Pleura
  • Mesotheliomas Pleural
  • Mesothelioma Peritoneum
  • Non Small Cell Lung Cancer
  • Non Small Cell Lung Cancer Metastatic
Interventions
  • Biological: gavo-cel
  • Drug: fludarabine
  • Drug: cyclophosphamide
Facility
  • University of California, San Francisco, San Francisco, California
  • University of Miami Sylvester Cancer Center, Miami, Florida
  • University of Chicago Medical Center, Chicago, Illinois
  • National Cancer Institute, Bethesda, Maryland
  • Columbia University Medical Center, New York, New York
  • Memorial Sloan Kettering Cancer Center, New York, New York
  • Duke University, Durham, North Carolina
  • University of Pennsylvania, Philadelphia, Pennsylvania
  • Sarah Cannon Research Institute, Nashville, Tennessee
  • University of Texas MD Anderson Cancer Center, Houston, Texas
Clinical Trial for Mesothelioma from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Location: Baltimore, Maryland (multiple locations)
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Mesothelioma from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma

Conditions
  • Mesothelioma
Interventions
  • Drug: Nivolumab Injection
Facility
  • Greenebaum Comprehensive Cancer Center University of Maryland School of Medicine, Baltimore, Maryland
  • Johns Hopkins University, Baltimore, Maryland
  • University of Texas M.D. Anderson Cancer Center, Houston, Texas
Clinical Trial for Mesothelioma from Mayo Clinic
Location: Rochester, Minnesota
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Mesothelioma from Mayo Clinic

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
Staging Procedures to Diagnose Malignant Pleural Mesothelioma

Conditions
  • Mesothelioma
  • Solitary Fibrous Tumor of the Pleura
Facility
  • Mayo Clinic in Rochester, Rochester, Minnesota
Clinical Trial for Mesothelioma from TCR2 Therapeutics
Location: Bethesda, Maryland (multiple locations)
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Mesothelioma from TCR2 Therapeutics

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Conditions
  • Mesothelioma
  • Mesotheliomas Pleural
  • Mesothelioma, Malignant
  • Mesothelioma Peritoneum
Interventions
  • Biological: TC-510
  • Drug: Fludarabine
  • Drug: Cyclophosphamide
Facility
  • National Cancer Institute, Bethesda, Maryland
  • University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota
  • Montefiore Einstein Cancer Center, Bronx, New York
  • Sarah Cannon Research Institute, Nashville, Tennessee
Clinical Trial for Uveal Melanoma from Ohio State University
Location: Columbus, Ohio
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Uveal Melanoma from Ohio State University

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

Conditions
  • BAP1 Gene Mutation
  • Mesothelioma
Facility
  • The Ohio State University Wexner Medical Center, Columbus, Ohio
Clinical Trial for Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC)
Location: Bethesda, Maryland
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC)

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies

Conditions
  • Peritoneal Carcinomatosis
  • Peritoneal Mesothelioma
Interventions
  • Procedure: Heated Intraperitonial Chemotherapy
  • Drug: Oxaliplatin
  • Drug: 5-Fluorouracil
Facility
  • National Institutes of Health Clinical Center, Bethesda, Maryland
Clinical Trial for Cancer from Aminex Therapeutics, Inc.
Location: Phoenix, Arizona (multiple locations)
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Cancer from Aminex Therapeutics, Inc.

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
A Phase 1B/2A Study of the Safety, Tolerability and Initial Efficacy of Oral AMXT 1501 Dicaprate and Intravenous Difluoromethylornithine (DFMO) in Patients With Cancer

Conditions
  • Nsclc
  • Mesotheliomas Pleural
  • Mesothelioma Peritoneum
Interventions
  • Drug: AMXT1501
  • Drug: DFMO
Facility
  • Mayo Clinic - Arizona, Phoenix, Arizona
  • Mayo Clinic - Florida, Jacksonville, Florida
  • Mayo Clinic - Minnesota, Rochester, Minnesota
  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
  • MD Anderson Cancer Center, Houston, Texas
  • Fred Hutch Cancer Center - Seattle Cancer Care Alliance, Seattle, Washington
Clinical Trial for Adenocarcinoma from Taproot Health
Location: Idaho Falls, Idaho (multiple locations)
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Adenocarcinoma from Taproot Health

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)

Conditions
  • Lung Cancer
  • Mesothelioma
Interventions
  • Diagnostic Test: Biomarker Testing (L)
  • Drug: Systemic Treatment (T)
Facility
  • Teton Cancer Institute, Idaho Falls, Idaho
  • Oncology and Hematology of South Texas, Laredo, Texas
Clinical Trial for Solid Tumor, Adult from Vivace Therapeutics, Inc
Location: Chicago, Illinois (multiple locations)
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Solid Tumor, Adult from Vivace Therapeutics, Inc

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
Phase 1, Multi-Center, Open-Label, Study to Evaluate the Safety, Tolerability, and PK of VT3989 in Patients With Refractory Locally Advanced or Metastatic Solid Tumors Enriched for Tumors Harboring Mutations of the NF2 Gene

Conditions
  • Mesothelioma
Interventions
  • Drug: VT3989
Facility
  • University of Chicago Medical Center, Chicago, Illinois
  • Massachusetts General Hospital, Boston, Massachusetts
  • Dana-Farber Cancer Institute, Boston, Massachusetts
  • MD Anderson Cancer Center, Houston, Texas
  • NEXT Oncology, San Antonio, Texas
Clinical Trial for Peritoneal Diseases from Hospices Civils de Lyon
Location: Dallas, Texas (multiple locations)
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Peritoneal Diseases from Hospices Civils de Lyon

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
Feasibility and Clinical Results of Implementation of ERAS® Guidelines for Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: an International Prospective Cohort Study

Conditions
  • Peritoneal Diseases
Interventions
  • Other: Pre-ERAS® phase (current clinical practice)
Facility
  • University of Texas Southwestern Medical Center, Dallas, Texas
Clinical Trial for Cutaneous Melanoma from Seagen Inc.
Location: San Francisco, California (multiple locations)
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Cutaneous Melanoma from Seagen Inc.

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
A Phase 1 Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Conditions
  • Non-small Cell Lung Cancer
  • Mesothelioma
Interventions
  • Drug: SGN-BB228
Facility
  • University of California at San Francisco, San Francisco, California
  • Sarah Cannon Research Institute at HealthONE - Denver, Denver, Colorado
  • NYU Langone Hospital, New York, New York
Clinical Trial for Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center
Location: Houston, Texas
Call (855) 947-1097 to get help enrolling in this clinical trial
Clinical Trial for Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center

Our Patient Advocates can help you connect with clinical trials

Call (855) 947–1097 to get started

Trial Name
Phase I/II Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

Conditions
    Interventions
    • Drug: CAR.70/IL15-transduced CB-derived NK cells
    • Drug: Fludarabine phosphate
    • Drug: Cyclophosphamide
    Facility
    • M D Anderson Cancer Center, Houston, Texas
    Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.
    Location: Gilbert, Arizona (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    An Observational Study Obtaining Solid Tumor Tissue From Participants and Apheresis for CAR T-Cell Therapy Manufacturing

    Conditions
    • Non Small Cell Lung Cancer
    • Mesothelioma
    • Mesothelioma, Malignant
    • Mesothelioma; Lung
    Facility
    • Banner Health, Gilbert, Arizona
    • City of Hope, Duarte, California
    • University of California San Diego, La Jolla, California
    • Stanford University, Palo Alto, California
    • UCLA Medical Center, Santa Monica, California
    • Mayo Clinic Jacksonville, Jacksonville, Florida
    • Moffitt Cancer Center, Tampa, Florida
    • Massachusetts General Hospital/Dana Farber Cancer Institute, Boston, Massachusetts
    • Mayo Clinic Rochester, Rochester, Minnesota
    • Washington University, Saint Louis, Missouri
    • NYU Langone Medical Center, New York, New York
    • MD Anderson Cancer Center, Houston, Texas
    • Fred Hutchinson Cancer Center, Seattle, Washington
    Clinical Trial for Ovarian Cancer from ProfoundBio US Co.
    Location: Los Angeles, California (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Ovarian Cancer from ProfoundBio US Co.

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    Phase 1/2 Study of PRO1184 in Patients With Locally Advanced and/or Metastatic Solid Tumors

    Conditions
    • Primary Peritoneal Carcinoma
    • Non-small Cell Lung Cancer
    • Mesothelioma
    Interventions
    • Drug: PRO1184
    Facility
    • University of California Los Angeles Medical Center, Los Angeles, California
    • University of California, San Diego; Moores Cancer Center, San Diego, California
    • Providence Medical Foundation, Santa Rosa, California
    • University of Kansas Medical Center (KUMC), Westwood, Kansas
    • Massachusetts General Hospital, Boston, Massachusetts
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • Karmanos Cancer Institute, Detroit, Michigan
    • University of Oklahoma - Health Sciences Center, Oklahoma City, Oklahoma
    • Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee
    • Mary Crowley Cancer Research, Dallas, Texas
    • START Mountain Region, West Valley City, Utah
    Clinical Trial for Pleural Mesothelioma from University of Chicago
    Location: Chicago, Illinois
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Pleural Mesothelioma from University of Chicago

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    A Pilot Window-of-opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

    Conditions
    • Pleural Mesothelioma
    Interventions
    • Drug: Pembrolizumab
    • Drug: Cisplatin and Pemetrexed
    Facility
    • University of Chicago, Chicago, Illinois
    Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center
    Location: Basking Ridge, New Jersey (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    Phase I Dose Escalation and Local Control Study of Pembrolizumab + Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma

    Conditions
    • Malignant Pleural Mesothelioma
    Interventions
    • Drug: Pembrolizumab
    • Radiation: IMPRINT
    Facility
    • Memoral Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey
    • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey
    • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
    • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack, New York
    • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York
    • Memorial Sloan Kettering Cancer Center, New York, New York
    • Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York
    Clinical Trial for Gastric Cancer from HiFiBiO Therapeutics
    Location: Scottsdale, Arizona (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Gastric Cancer from HiFiBiO Therapeutics

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    A Phase 1a/1b, Open-Label, Multi-Center, Dose Escalation and Expansion Study of HFB200301 (TNFR2 Agonist Antibody) as a Single Agent and in Combination With Tislelizumab (Anti-PD-1 Antibody) in Adult Patients With Advanced Solid Tumors

    Conditions
    • Mesothelioma
    • Non Small Cell Lung Cancer
    Interventions
    • Drug: HFB200301
    Facility
    • Mayo Clinic, Scottsdale, Arizona
    • USC/Norris Comprehensive Cancer Center, Los Angeles, California
    • Mayo Clinic, Jacksonville, Florida
    • Mayo Clinic, Rochester, Minnesota
    • Washington University School of Medicine, Saint Louis, Missouri
    • The University of Texas, MD Anderson Cancer Center, Houston, Texas
    • NEXT Virginia Cancer Specialists, Fairfax, Virginia
    Clinical Trial for Solid Tumors from Inhibrx, Inc.
    Location: Scottsdale, Arizona (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Solid Tumors from Inhibrx, Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    An Open-Label, Multicenter, First-in-Human, Phase 1 Dose-Escalation and Multicohort Expansion Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

    Conditions
    • Malignant Pleural Mesothelioma
    Interventions
    • Drug: INBRX-109
    Facility
    • HonorHealth Research Institute, Scottsdale, Arizona
    • City of Hope, Duarte, California
    • Valkyrie Clinical Trials, Los Angeles, California
    • Sarcoma Oncology Center, Santa Monica, California
    • University of Colorado Hospital, Aurora, Colorado
    • Emory University - Winship Cancer Institute, Atlanta, Georgia
    • The University of Chicago, Chicago, Illinois
    • University of Michigan, Ann Arbor, Michigan
    • START Midwest Michigan, PC, Grand Rapids, Michigan
    • Haley Phelan, New York, New York
    • Cleveland Clinic, Cleveland, Ohio
    • University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania
    • UT MD Anderson Cancer Center, Houston, Texas
    • NEXT Oncology, San Antonio, Texas
    • NEXT Oncology - Virginia, Fairfax, Virginia
    Clinical Trial for Advanced Cancer from Merck Sharp & Dohme LLC
    Location: Los Angeles, California (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Advanced Cancer from Merck Sharp & Dohme LLC

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)

    Conditions
    • Small Cell Lung Carcinoma
    • Small Cell Lung Cancer (SCLC)
    • Mesothelioma
    Interventions
    • Biological: pembrolizumab
    Facility
    • Call for Information (Investigational Site 0202), Los Angeles, California
    • Call for Information (Investigational Site 0017), Los Angeles, California
    • Call for Information (Investigational Site 0010), Boston, Massachusetts
    • Call for Information (Investigational Site 0008), New Brunswick, New Jersey
    Clinical Trial for Mesothelioma from ProgenaBiome
    Location: Ventura, California
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from ProgenaBiome

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

    Conditions
    • Mesothelioma
    • Mesothelioma Malignant
    • Mesothelioma; Lung
    • Mesotheliomas Pleural
    • Mesothelioma Peritoneum
    • Mesothelioma; Omentum
    Interventions
    • Other: No intervention
    Facility
    • ProgenaBiome, Ventura, California
    Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center
    Location: Basking Ridge, New Jersey (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    Feasibility and Safety of Neoadjuvant Nivolumab and Chemotherapy for Resectable Malignant Pleural Mesothelioma

    Conditions
    • Malignant Pleural Mesothelioma
    Interventions
    • Drug: Nivolumab
    • Drug: Pemetrexed
    • Drug: Cisplatin or Carboplatin
    Facility
    • Memoiral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
    • Memorial Sloan Kettering Monmouth, Middletown, New Jersey
    • Memorial Sloan Kettering Bergen, Montvale, New Jersey
    • Memorial Sloan Kettering Commack, Commack, New York
    • Memorial Sloan Kettering Westchester, Harrison, New York
    • Memorial Sloan Kettering Cancer Center, New York, New York
    • Memorial Sloan Kettering Nassau, Uniondale, New York
    Clinical Trial for Lung Cancer from Memorial Sloan Kettering Cancer Center
    Location: Basking Ridge, New Jersey (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Lung Cancer from Memorial Sloan Kettering Cancer Center

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    A Phase 1 Study of Pembrolizumab Plus Cryoablation in Patients With Unresectable Mesotheliomas

    Conditions
    • Lung Cancer
    • Unresectable Mesothelioma
    Interventions
    • Drug: Pembrolizumab
    • Procedure: Image-guided cryoablation
    Facility
    • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey
    • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey
    • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
    • Memorial Sloan Kettering Commack (Limited protocol activities), Commack, New York
    • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York
    • Memorial Sloan Kettering Cancer Center (All protocol activities), New York, New York
    • Memorial Sloan Kettering Nassau (Limited protocol activities), Uniondale, New York
    Clinical Trial for Mesothelioma from NGM Biopharmaceuticals, Inc
    Location: Los Angeles, California (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from NGM Biopharmaceuticals, Inc

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    A Phase 1/2 Dose Escalation/Expansion Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

    Conditions
    • Mesothelioma
    • Non Small Cell Lung Cancer
    Interventions
    • Drug: NGM707
    Facility
    • University of Southern California, Los Angeles, California
    • Hoag Memorial Hospital Presbyterian, Newport Beach, California
    • UCLA Medical Center, Santa Monica, California
    • Georgetown University Medical Center, Washington, District of Columbia
    • Florida Cancer Specialists - Sarasota - SCRI, Sarasota, Florida
    • University of Maryland Greenebaum Cancer Center, Baltimore, Maryland
    • Dana-Farber Cancer Institute, Boston, Massachusetts
    • START Midwest, LLC, Grand Rapids, Michigan
    • Nebraska Cancer Specialists, Omaha, Nebraska
    • Prisma Health - Upstate, Greenville, South Carolina
    • University of Texas Southwestern Medical Center, Dallas, Texas
    • MD Anderson Cancer Center, Houston, Texas
    • NEXT Oncology, San Antonio, Texas
    Clinical Trial for Pancreatic Cancer from Takeda
    Location: Duarte, California (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Pancreatic Cancer from Takeda

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    An Open-label, Dose Escalation and Expansion, Phase 1a/1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-500, a Novel Stimulator of Interferon Genes Agonist, as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Select Locally Advanced or Metastatic Solid Tumors

    Conditions
    • Mesothelioma
    • Non-small Cell Lung Cancer (NSCLC), Non-squamous
    Interventions
    • Drug: TAK-500
    Facility
    • City of Hope, Duarte, California
    • University of California San Diego, La Jolla, California
    • University of Colorado - Anschutz Medical Campus - PPDS, Aurora, Colorado
    • Sarah Cannon Research Institute, Denver, Colorado
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • Fox Chase Cancer Center, Philadelphia, Pennsylvania
    • START South Texas Accelerated Research Therapeutics, San Antonio, Texas
    Clinical Trial for Solid Tumor from Astex Pharmaceuticals, Inc.
    Location: Duarte, California (multiple locations)
    Call (855) 947-1097 to get help enrolling in this clinical trial
    Clinical Trial for Solid Tumor from Astex Pharmaceuticals, Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (855) 947–1097 to get started

    Trial Name
    Phase 1/2 Open-Label Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX295 in Subjects With Wild-Type TP53 Advanced Solid Tumors

    Conditions
      Interventions
      • Drug: ASTX295
      Facility
      • City of Hope Comprehensive Cancer Center Site#114, Duarte, California
      • Cedars-Sinai Medical Center Site #105, Los Angeles, California
      • Hoag Hospital Site#110, Newport Beach, California
      • Holden Comprehensive Cancer Center Site#108, Iowa City, Iowa
      • University of Michigan Rogel Cancer Center Site#109, Ann Arbor, Michigan
      • Regions Cancer Center Site #115, Saint Paul, Minnesota
      • Columbia University Irving Medical Center - Herbert Irving Pavilion Site#104, New York, New York
      • University of Pennsylvania-Abramson Cancer Center Site#113, Philadelphia, Pennsylvania
      • The University of Texas MD Anderson Cancer Center Site #102, Houston, Texas
      • NEXT Oncology Site #101, San Antonio, Texas
      • Virgnia Cancer Specialists Site #103, Fairfax, Virginia
      Clinical Trial for Mesothelioma from Mirati Therapeutics Inc.
      Location: Phoenix, Arizona (multiple locations)
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Mesothelioma from Mirati Therapeutics Inc.

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1719 in Patients With Advanced Solid Tumors With MTAP Homozygous Deletion

      Conditions
      • Mesothelioma
      • Non Small Cell Lung Cancer
      Interventions
      • Drug: MRTX1719
      Facility
      • Mayo Clinic, Phoenix, Arizona
      • Sarah Cannon Research Institute at HealthONE, Denver, Colorado
      • Mayo Clinic, Jacksonville, Florida
      • Dana Farber Cancer Institute, Boston, Massachusetts
      • Mayo Clinic, Rochester, Minnesota
      • Memorial Sloan Kettering Cancer Center, New York, New York
      • NorthShore Hematology Oncology Associates P.C New York Cancer and Blood Specialists, Port Jefferson Station, New York
      • Sarah Cannon Research Institute, Nashville, Tennessee
      • MD Anderson Cancer Center, Houston, Texas
      • START Center for Cancer Care, San Antonio, Texas
      Clinical Trial for Pancreas Cancer from Dana-Farber Cancer Institute
      Location: Boston, Massachusetts (multiple locations)
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Pancreas Cancer from Dana-Farber Cancer Institute

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      A Master Protocol of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART)

      Conditions
      • Lung Cancer
      • Mesothelioma
      Interventions
      • Radiation: MR-guided Linac
      Facility
      • Brigham & Women's Hospital, Boston, Massachusetts
      • Dana Farber Cancer Institute, Boston, Massachusetts
      Clinical Trial for Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine
      Location: Philadelphia, Pennsylvania
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

      Conditions
      • Mesotheliomas Pleural
      Interventions
      • Drug: Pembrolizumab
      • Procedure: Indocyanine Green (ICG) Image-Guided Surgery
      • Drug: Cisplatin
      • Drug: Pemetrexed
      Facility
      • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania
      Clinical Trial for Mesothelioma from PrECOG, LLC.
      Location: La Jolla, California (multiple locations)
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Mesothelioma from PrECOG, LLC.

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial

      Conditions
      • Mesothelioma
      • Pleural Mesothelioma
      • Malignant Pleural Mesothelioma
      Interventions
      • Drug: Durvalumab
      Facility
      • University of California San Diego, La Jolla, California
      • University of Miami, Miami, Florida
      • Moffitt Cancer Center, Tampa, Florida
      • Emory University, Atlanta, Georgia
      • University of Chicago, Chicago, Illinois
      • NorthShore University Health System/Kellogg Cancer Center, Evanston, Illinois
      • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
      • Massaschusetts General Hospital, Boston, Massachusetts
      • Dana Farber Cancer Institute, Boston, Massachusetts
      • University of Michigan, Ann Arbor, Michigan
      • Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota
      • Morristown Medical/Atlantic Health, Morristown, New Jersey
      • Jersey Shore University Medical Center, Neptune, New Jersey
      • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
      • Memorial Sloan Kettering, New York, New York
      • University of Cincinnati, Cincinnati, Ohio
      • Cleveland Clinic Foundation, Cleveland, Ohio
      • The Ohio State University, Columbus, Ohio
      • Penn State Cancer Institute, Hershey, Pennsylvania
      • Abramson Cancer Cener at Penn Presbyterian Medical Center, Philadelphia, Pennsylvania
      • Fox Chase Cancer Center, Philadelphia, Pennsylvania
      • Allegheny Cancer Center, Pittsburgh, Pennsylvania
      • Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
      • University of Texas Southwestern Medical Center, Dallas, Texas
      • Baylor College of Medicine, Houston, Texas
      • MD Anderson Cancer Center, Houston, Texas
      • University of Virginia, Charlottesville, Virginia
      Clinical Trial for Malignant Pleural Mesothelioma from Oncovir, Inc.
      Location: New York, New York
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Malignant Pleural Mesothelioma from Oncovir, Inc.

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      Direct Injection of Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma

      Conditions
      • Malignant Pleural Mesothelioma
      Interventions
      • Biological: Safety
      Facility
      • Icahn School of Medicine Mount Sinai, New York, New York
      Clinical Trial for Malignant Mesothelioma from Roswell Park Cancer Institute
      Location: Buffalo, New York
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Malignant Mesothelioma from Roswell Park Cancer Institute

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      Light Dosimetry for Intraoperative Photodynamic Therapy (IO-PDT) With Porfimer Sodium (Photofrin) in Patients With Malignant Mesothelioma or Non-Small Cell Lung Cancer (NSCLC), or Other Malignancies With Pleural Disease - Phase I Study

      Conditions
      • Malignant Mesothelioma
      • Non-Small Cell Lung Carcinoma
      • Pleural Disorder
      Interventions
      • Device: Light Dosimetry for Intranoperative Therapy
      • Procedure: Photodynamic Therapy
      • Drug: Porfimer Sodium
      Facility
      • Roswell Park Cancer Institute, Buffalo, New York
      Clinical Trial for Thymus Tumors from National Institutes of Health Clinical Center (CC)
      Location: Bethesda, Maryland
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Thymus Tumors from National Institutes of Health Clinical Center (CC)

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      Inpatient Hospice With Procurement of Tissue on Expiration in Thoracic Malignancies, Bladder Cancer, Ovarian Cancer, Epithelial Cancer and Patients Treated With an Adoptive Cellular Therapy

      Conditions
      • Mesothelioma
      • Lung Cancers
      Facility
      • National Institutes of Health Clinical Center, Bethesda, Maryland
      Clinical Trial for Pleural Mesothelial Neoplasm from Mayo Clinic
      Location: Rochester, Minnesota
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Pleural Mesothelial Neoplasm from Mayo Clinic

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      SBRT With Immunotherapy for Mesothelioma

      Conditions
      • Pleural Mesothelial Neoplasm
      Interventions
      • Other: Immunotherapy
      • Other: Quality-of-Life Assessment
      • Radiation: Stereotactic Body Radiation Therapy
      Facility
      • Mayo Clinic in Rochester, Rochester, Minnesota
      Clinical Trial for Advanced Solid Tumor from Medicenna Therapeutics, Inc.
      Location: Santa Monica, California (multiple locations)
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Advanced Solid Tumor from Medicenna Therapeutics, Inc.

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      A Phase 1/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination With Immune Checkpoint Inhibitor in Patients With Advanced Solid Tumors

      Conditions
      • Non-Small Cell Lung Cancer Squamous
      • Non-Small Cell Lung Cancer Non-squamous
      • Pleural Mesothelioma
      Interventions
      • Drug: MDNA11 Monotherapy
      • Drug: MDNA11 in combination with checkpoint inhibitor
      Facility
      • Providence Saint John's Health Center, Santa Monica, California
      • Boca Raton Regional Hospital, Boca Raton, Florida
      • Orlando Health Cancer Institute, Orlando, Florida
      • Emory - Winship Cancer Institute, Atlanta, Georgia
      Clinical Trial for Mesothelioma from Mayo Clinic
      Location: Rochester, Minnesota
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Mesothelioma from Mayo Clinic

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

      Conditions
      • Mesothelioma
      • Solitary Fibrous Tumor of the Pleura
      Facility
      • Mayo Clinic in Rochester, Rochester, Minnesota
      Clinical Trial for Malignant Pleural Mesotheliomas (Mpm) from National Institutes of Health Clinical Center (CC)
      Location: Bethesda, Maryland
      Call (855) 947-1097 to get help enrolling in this clinical trial
      Clinical Trial for Malignant Pleural Mesotheliomas (Mpm) from National Institutes of Health Clinical Center (CC)

      Our Patient Advocates can help you connect with clinical trials

      Call (855) 947–1097 to get started

      Trial Name
      Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

      Conditions
        Interventions
        • Procedure: Cytoreductive surgery
        • Drug: LMB-100
        • Diagnostic Test: Immunohistochemical Assay for Mesothelin
        Facility
        • National Institutes of Health Clinical Center, Bethesda, Maryland
        Clinical Trial for CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center
        Location: Houston, Texas
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        Phase II Trial of Adcetris (Brentuximab Vedotin) in CD30+ Malignant Mesothelioma

        Conditions
        • Malignant Mesothelioma
        Interventions
        • Drug: Brentuximab Vedotin
        • Other: Laboratory Biomarker Analysis
        Facility
        • M D Anderson Cancer Center, Houston, Texas
        Clinical Trial for Advanced Bile Duct Carcinoma from National Cancer Institute (NCI)
        Location: Sacramento, California (multiple locations)
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Advanced Bile Duct Carcinoma from National Cancer Institute (NCI)

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        A Phase 1 Trial of the ATR Inhibitor BAY 1895344 in Combination With Cisplatin and With Cisplatin Plus Gemcitabine in Advanced Solid Tumors With an Emphasis on Urothelial Carcinoma

        Conditions
        • Advanced Lung Non-Small Cell Carcinoma
        • Advanced Lung Small Cell Carcinoma
        • Advanced Pleural Malignant Mesothelioma
        • Stage III Lung Cancer AJCC v8
        • Stage III Pleural Malignant Mesothelioma AJCC v8
        • Stage IV Lung Cancer AJCC v8
        • Stage IV Pleural Malignant Mesothelioma AJCC v8
        Interventions
        • Drug: Cisplatin
        • Drug: Elimusertib
        Facility
        • University of California Davis Comprehensive Cancer Center, Sacramento, California
        • National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland
        • National Institutes of Health Clinical Center, Bethesda, Maryland
        • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
        • Ohio State University Comprehensive Cancer Center, Columbus, Ohio
        • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
        • University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
        Clinical Trial for Peritoneal Metastases from Lumicell, Inc.
        Location: Boston, Massachusetts
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Peritoneal Metastases from Lumicell, Inc.

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        Feasibility of the LUM Imaging System for Detection of Peritoneal Surface Malignancies

        Conditions
        • Peritoneal Metastases
        Interventions
        • Combination Product: LUM Imaging System
        Facility
        • Massachusetts General Hospital, Boston, Massachusetts
        Clinical Trial for Breast Cancer from Prelude Therapeutics
        Location: Miami, Florida (multiple locations)
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Breast Cancer from Prelude Therapeutics

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

        Conditions
        • Malignant Mesothelioma
        • Non-small Cell Lung Cancers
        Interventions
        • Drug: PRT3645
        Facility
        • Miami Cancer Institute, Miami, Florida
        • Florida Cancer Specialists, Sarasota, Florida
        • Winship Cancer Institute, Emory University, Atlanta, Georgia
        • Cleveland Clinic, Cleveland, Ohio
        • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania
        • Tennessee Oncology, PLLC, Nashville, Tennessee
        • South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas
        • NEXT Virginia, Fairfax, Virginia
        Clinical Trial for Pleural Effusion, Malignant from Travera Inc
        Location: Oakland, California
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Pleural Effusion, Malignant from Travera Inc

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance

        Conditions
        • Pleural Effusion, Malignant
        • Ascites, Malignant
        • Mesothelioma
        Facility
        • xCures, Oakland, California
        Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)
        Location: Bethesda, Maryland
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma and Other Mesothelin Expressing Cancers

        Conditions
        • Mesothelioma
        Facility
        • National Institutes of Health Clinical Center, Bethesda, Maryland
        Clinical Trial for Mesothelioma from Novartis
        Location: Chicago, Illinois (multiple locations)
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Mesothelioma from Novartis

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        An Open-label, Multi-center, Phase I Study of Oral IAG933 in Adult Patients With Advanced Mesothelioma and Other Solid Tumors

        Conditions
        • Mesothelioma
        Interventions
        • Drug: IAG933
        Facility
        • University of Chicago Medical Center, Chicago, Illinois
        • Massachusetts General Hospital Massachusetts General Hospital, Boston, Massachusetts
        • Cleveland Clinic Foundation, Cleveland, Ohio
        • MD Anderson Cancer Center/University of Texas, Houston, Texas
        Clinical Trial for Triple Negative Breast Cancer from A&G Pharmaceutical Inc.
        Location: Baltimore, Maryland
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Triple Negative Breast Cancer from A&G Pharmaceutical Inc.

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        FIH Phase 1A /1B Study of AG01 Antibody Against Progranulin/GP88 in Advanced Solid Tumor Malignancies With Expansion Cohorts in Advanced Triple Negative Breast Ca, Hormone Resistant Breast Ca, Non Small Cell Lung Cancer and Mesothelioma

        Conditions
        • Non Small Cell Lung Cancer
        • Mesothelioma
        Interventions
        • Drug: AG-01 Compound
        Facility
        • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland
        Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)
        Location: Bethesda, Maryland
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes

        Conditions
        • Mesothelioma
        Facility
        • National Institutes of Health Clinical Center, Bethesda, Maryland
        Clinical Trial for Lung Non-Small Cell Carcinoma from Roswell Park Cancer Institute
        Location: Buffalo, New York
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Lung Non-Small Cell Carcinoma from Roswell Park Cancer Institute

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        Utilizing Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC) With Pleural Disease or Malignant Pleural Mesothelioma (MPM) - Phase I Study

        Conditions
        • Pleural Disorder
        Interventions
        • Drug: Porfimer Sodium
        • Procedure: Video-Assisted Thoracic Surgery
        • Drug: Photodynamic Therapy
        • Device: Intraoperative PDT
        Facility
        • Roswell Park Cancer Institute, Buffalo, New York
        Clinical Trial for Epitheliod Malignant Pleural Mesothelioma from Abramson Cancer Center at Penn Medicine
        Location: Buffalo, New York (multiple locations)
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Epitheliod Malignant Pleural Mesothelioma from Abramson Cancer Center at Penn Medicine

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        A Randomized Phase 2 Trial of Radical Pleurectomy and Post-Operative Chemotherapy With or Without Intraoperative Porfimer Sodium -Mediated Photodynamic Therapy for Patients With Epitheliod Malignant Pleural Mesothelioma

        Conditions
        • Epitheliod Malignant Pleural Mesothelioma
        Interventions
        • Radiation: Photodynamic Therapy
        • Procedure: Radical Pleurectomy
        • Radiation: Chemotherapy
        • Drug: Photofrin 2.0 mg/kg
        Facility
        • Rosewell Park, Buffalo, New York
        • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania
        Clinical Trial for Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC)
        Location: Bethesda, Maryland
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC)

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        Prospective Evaluation of Genetic and Epigenetic Alterations in Patients With Thoracic Malignancies

        Conditions
        • Malignant Pleural Mesotheliomas NOS
        • Lung Cancer NOS
        • Thoracic Cancers
        Facility
        • National Institutes of Health Clinical Center, Bethesda, Maryland
        Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.
        Location: Boston, Massachusetts (multiple locations)
        Call (855) 947-1097 to get help enrolling in this clinical trial
        Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.

        Our Patient Advocates can help you connect with clinical trials

        Call (855) 947–1097 to get started

        Trial Name
        A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG908 in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors

        Conditions
          Interventions
          • Drug: TNG908
          Facility
          • Massachusetts General Hospital, Boston, Massachusetts
          • Dana Farber Cancer Institute, Boston, Massachusetts
          • Washington University, Saint Louis, Missouri
          • Sarah Cannon Tennessee Oncology, Nashville, Tennessee
          • The University of Texas MD Anderson Cancer Center, Houston, Texas
          • NEXT Oncology, Fairfax, Virginia
          Clinical Trial for Mesothelioma from University of Chicago
          Location: Chicago, Illinois
          Call (855) 947-1097 to get help enrolling in this clinical trial
          Clinical Trial for Mesothelioma from University of Chicago

          Our Patient Advocates can help you connect with clinical trials

          Call (855) 947–1097 to get started

          Trial Name
          Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma

          Conditions
          • Mesothelioma
          • Peritoneal Mesothelioma
          Interventions
          • Diagnostic Test: HR-MRI
          • Diagnostic Test: Standard CT Imaging
          Facility
          • University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois
          Clinical Trial for Pleural Biphasic Mesothelioma from NRG Oncology
          Location: Coral Gables, Florida (multiple locations)
          Call (855) 947-1097 to get help enrolling in this clinical trial
          Clinical Trial for Pleural Biphasic Mesothelioma from NRG Oncology

          Our Patient Advocates can help you connect with clinical trials

          Call (855) 947–1097 to get started

          Trial Name
          Phase III Randomized Trial of Pleurectomy/Decortication Plus Systemic Therapy With or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma (MPM)

          Conditions
          • Pleural Biphasic Mesothelioma
          • Pleural Epithelioid Mesothelioma
          • Stage I Pleural Malignant Mesothelioma AJCC v8
          • Stage IA Pleural Malignant Mesothelioma AJCC v8
          • Stage IB Pleural Malignant Mesothelioma AJCC v8
          • Stage II Pleural Malignant Mesothelioma AJCC v8
          • Stage IIIA Pleural Malignant Mesothelioma AJCC v8
          Interventions
          • Drug: Carboplatin
          • Drug: Cisplatin
          • Procedure: Decortication
          • Drug: Pemetrexed
          • Drug: Pemetrexed Disodium
          • Procedure: Pleurectomy
          • Other: Quality-of-Life Assessment
          • Other: Questionnaire Administration
          Facility
          • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida
          • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida
          • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
          • Moffitt Cancer Center-International Plaza, Tampa, Florida
          • Moffitt Cancer Center - McKinley Campus, Tampa, Florida
          • Moffitt Cancer Center, Tampa, Florida
          • University of Chicago Comprehensive Cancer Center, Chicago, Illinois
          • Brigham and Women's Hospital, Boston, Massachusetts
          • Mayo Clinic in Rochester, Rochester, Minnesota
          • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
          • Memorial Sloan Kettering Monmouth, Middletown, New Jersey
          • Memorial Sloan Kettering Bergen, Montvale, New Jersey
          • Memorial Sloan Kettering Commack, Commack, New York
          • Memorial Sloan Kettering Westchester, Harrison, New York
          • Mount Sinai Hospital, New York, New York
          • Memorial Sloan Kettering Cancer Center, New York, New York
          • Memorial Sloan Kettering Nassau, Uniondale, New York
          • Cleveland Clinic Foundation, Cleveland, Ohio
          • Ohio State University Comprehensive Cancer Center, Columbus, Ohio
          • MD Anderson in The Woodlands, Conroe, Texas
          • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
          • M D Anderson Cancer Center, Houston, Texas
          • MD Anderson West Houston, Houston, Texas
          • MD Anderson League City, League City, Texas
          • MD Anderson in Sugar Land, Sugar Land, Texas
          • Swedish Medical Center-First Hill, Seattle, Washington
          Clinical Trial for Mesothelioma from Dana-Farber Cancer Institute
          Location: Boston, Massachusetts
          Call (855) 947-1097 to get help enrolling in this clinical trial
          Clinical Trial for Mesothelioma from Dana-Farber Cancer Institute

          Our Patient Advocates can help you connect with clinical trials

          Call (855) 947–1097 to get started

          Trial Name
          Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

          Conditions
          • Mesothelioma
          Interventions
          • Other: MPT Test
          • Other: CLDN15/VIM Test
          Facility
          • Brigham and Women's Hospital, Boston, Massachusetts
          Clinical Trial for Ovarian Cancer from Verismo Therapeutics
          Location: Philadelphia, Pennsylvania
          Call (855) 947-1097 to get help enrolling in this clinical trial
          Clinical Trial for Ovarian Cancer from Verismo Therapeutics

          Our Patient Advocates can help you connect with clinical trials

          Call (855) 947–1097 to get started

          Trial Name
          A Phase 1 Study of SynKIR-110, Autologous T Cells Transduced With Mesothelin KIR-CAR, in Subjects With Mesothelin-Expressing Advanced Ovarian Cancer, Cholangiocarcinoma, or Mesothelioma

          Conditions
          • Mesothelioma, Malignant
          Interventions
          • Biological: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
          Facility
          • University of Pennsylvania, Philadelphia, Pennsylvania
          Clinical Trial for Mesothelioma from University of Chicago
          Location: Chicago, Illinois
          Call (855) 947-1097 to get help enrolling in this clinical trial
          Clinical Trial for Mesothelioma from University of Chicago

          Our Patient Advocates can help you connect with clinical trials

          Call (855) 947–1097 to get started

          Trial Name
          Phase II Trial of Olaparib in Homologous Recombination Deficient (HRD) Malignant Mesothelioma

          Conditions
          • Mesothelioma
          Interventions
          • Drug: Olaparib
          Facility
          • University of Chicago Medical Center, Chicago, Illinois
          Clinical Trial for Locally Advanced Solid Tumor from Compass Therapeutics
          Location: Ocala, Florida (multiple locations)
          Call (855) 947-1097 to get help enrolling in this clinical trial
          Clinical Trial for Locally Advanced Solid Tumor from Compass Therapeutics

          Our Patient Advocates can help you connect with clinical trials

          Call (855) 947–1097 to get started

          Trial Name
          A Phase 1, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of CTX-471 Administered Either as a Monotherapy or in Combination With Pembrolizumab in Patients With Inadequate Responses to PD-1/PD-L1 Checkpoint Inhibitors in Metastatic or Locally Advanced Malignancies

          Conditions
          • Metastatic Cancer
          • Non-small Cell Lung Cancer
          • Small Cell Lung Cancer
          • Mesothelioma
          Interventions
          • Drug: CTX-471
          Facility
          • Ocala Oncology Center, Ocala, Florida
          • Hematology Oncology Associates Of The Treasure Coast, Port Saint Lucie, Florida
          • Massachusetts General Hospital, Boston, Massachusetts
          • Dana-Farber Cancer Institute, Boston, Massachusetts
          • Washington University School of Medicine, Siteman Cancer Center, Saint Louis, Missouri
          • Hackensack University Medical Center, Hackensack, New Jersey
          • Mt Sinai, New York, New York
          • Duke University School of Medicine, Durham, North Carolina
          • Institute for Translational Oncology Research (ITOR), Greenville, South Carolina
          • Mary Crowley Cancer Research, Dallas, Texas
          Clinical Trial for Advanced/Metastatic Solid Tumor from Kezar Life Sciences, Inc.
          Location: Los Angeles, California (multiple locations)
          Call (855) 947-1097 to get help enrolling in this clinical trial
          Clinical Trial for Advanced/Metastatic Solid Tumor from Kezar Life Sciences, Inc.

          Our Patient Advocates can help you connect with clinical trials

          Call (855) 947–1097 to get started

          Trial Name
          A Phase 1 Study of KZR-261, a Small Molecule Sec61 Inhibitor, in Subjects With Advanced Solid Malignancies

          Conditions
            Interventions
            • Drug: KZR-261
            Facility
            • Cedars Sinai Medical Center, Los Angeles, California
            • Moffitt Cancer Center, Tampa, Florida
            • Winship Cancer Institute of Emory University, Atlanta, Georgia
            • Fox Chase Cancer Center, Philadelphia, Pennsylvania
            • Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville, Nashville, Tennessee
            • START (South Texas Accelerated Research Therapeutics), San Antonio, Texas
            • Virginia Cancer Specialists (VCS), Fairfax, Virginia
            Clinical Trial for Solid Tumors With PTCH1 Loss-of-function Mutations from Endeavor Biomedicines, Inc.
            Location: Los Angeles, California (multiple locations)
            Call (855) 947-1097 to get help enrolling in this clinical trial
            Clinical Trial for Solid Tumors With PTCH1 Loss-of-function Mutations from Endeavor Biomedicines, Inc.

            Our Patient Advocates can help you connect with clinical trials

            Call (855) 947–1097 to get started

            Trial Name
            A Phase 2, Multi-Center Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

            Conditions
              Interventions
              • Drug: ENV-101 (taladegib)
              Facility
              • Research Site, Los Angeles, California
              • Research Site, San Diego, California
              • Research Site, Santa Rosa, California
              • Research Site, Tampa, Florida
              • Research Site, Zion, Illinois
              • Research Site, Covington, Louisiana
              • Research Site, Las Vegas, Nevada
              • Research Site, New York, New York
              • Research Site, Durham, North Carolina
              • Research Site, Cincinnati, Ohio
              • Research Site, Cleveland, Ohio
              • Research Site, Columbus, Ohio
              • Research Site, Pittsburgh, Pennsylvania
              • Research Site, Nashville, Tennessee
              • Research Site, Houston, Texas
              • Research Site, Fredericksburg, Virginia
              • Research Site, Lynchburg, Virginia
              • Research Site, Madison, Wisconsin
              Clinical Trial for Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI)
              Location: Phoenix, Arizona (multiple locations)
              Call (855) 947-1097 to get help enrolling in this clinical trial
              Clinical Trial for Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI)

              Our Patient Advocates can help you connect with clinical trials

              Call (855) 947–1097 to get started

              Trial Name
              Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

              Conditions
              • Peritoneal Malignant Mesothelioma
              Interventions
              • Biological: Atezolizumab
              • Biological: Bevacizumab
              • Procedure: Biospecimen Collection
              • Drug: Carboplatin
              • Procedure: Computed Tomography
              • Procedure: Cytoreductive Surgery
              • Drug: Hyperthermic Intraperitoneal Chemotherapy
              • Drug: Pemetrexed
              • Procedure: Positron Emission Tomography
              Facility
              • Mayo Clinic Hospital in Arizona, Phoenix, Arizona
              • University of Chicago Comprehensive Cancer Center, Chicago, Illinois
              • Carle at The Riverfront, Danville, Illinois
              • Carle Physician Group-Effingham, Effingham, Illinois
              • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois
              • Carle Cancer Center, Urbana, Illinois
              • The Carle Foundation Hospital, Urbana, Illinois
              • University of Kentucky/Markey Cancer Center, Lexington, Kentucky
              • Alliance for Clinical Trials in Oncology, Boston, Massachusetts
              • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota
              • Fairview Southdale Hospital, Edina, Minnesota
              • Unity Hospital, Fridley, Minnesota
              • Abbott-Northwestern Hospital, Minneapolis, Minnesota
              • Mayo Clinic in Rochester, Rochester, Minnesota
              • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota
              • Regions Hospital, Saint Paul, Minnesota
              • United Hospital, Saint Paul, Minnesota
              • Sanford Bismarck Medical Center, Bismarck, North Dakota
              • Sanford Broadway Medical Center, Fargo, North Dakota
              • Sanford Roger Maris Cancer Center, Fargo, North Dakota
              • Ohio State University Comprehensive Cancer Center, Columbus, Ohio
              • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
              • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
              • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota
              • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota
              • M D Anderson Cancer Center, Houston, Texas
              • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin
              • Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin
              Clinical Trial for Advanced Solid Tumors from Incyte Corporation
              Location: Hackensack, New Jersey (multiple locations)
              Call (855) 947-1097 to get help enrolling in this clinical trial
              Clinical Trial for Advanced Solid Tumors from Incyte Corporation

              Our Patient Advocates can help you connect with clinical trials

              Call (855) 947–1097 to get started

              Trial Name
              A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Select Advanced Solid Tumors

              Conditions
              • Small-cell Lung Cancer
              • Mesothelioma
              Interventions
              • Drug: INCB099318
              Facility
              • Hackensack University Medical Center, Hackensack, New Jersey
              • Prisma Health Cancer Institute Faris, Greenville, South Carolina
              • Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
              Clinical Trial for Any Solid Tumors Progressed After a Prior Immunotherapy from VM Oncology, LLC
              Location: Duarte, California (multiple locations)
              Call (855) 947-1097 to get help enrolling in this clinical trial
              Clinical Trial for Any Solid Tumors Progressed After a Prior Immunotherapy from VM Oncology, LLC

              Our Patient Advocates can help you connect with clinical trials

              Call (855) 947–1097 to get started

              Trial Name
              An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects With Solid Tumors or Lymphoma

              Conditions
              • Mesothelioma
              Interventions
              • Drug: VMD-928 300 mg Tablet (ongoing); 100 mg Capsule (complete)
              Facility
              • City of Hope National Medical Center, Duarte, California
              • Memorial Cancer Institute at Memorial Healthcare Systems, Pembroke Pines, Florida
              • Atlantic Health System, Morristown Medical Center, Morristown, New Jersey
              • Weill Cornell Medicine, Cornell University, New York, New York
              • Gabrail Cancer Center Research, Canton, Ohio
              • Erlanger Health System (Hospital); University of Tennessee College of Medicine, Chattanooga, Chattanooga, Tennessee
              • The University of Texas MD Anderson Cancer Center, Houston, Texas
              • Medical College of Wisconsin, Milwaukee, Wisconsin
              Clinical Trial for Malignant Abdominal Neoplasm from Mayo Clinic
              Location: Rochester, Minnesota
              Call (855) 947-1097 to get help enrolling in this clinical trial
              Clinical Trial for Malignant Abdominal Neoplasm from Mayo Clinic

              Our Patient Advocates can help you connect with clinical trials

              Call (855) 947–1097 to get started

              Trial Name
              A Prospective Study of Heated Intra-Peritoneal Chemotherapy (H.I.P.E.C.) With Doxorubicin and Cisplatin in Pediatric Patients With Pelvic and Abdominal Tumors. The TOAST IT Trial (Trial Of Adjuvant Surgical Treatment With Intraperitoneal Chemotherapy)

              Conditions
              • Recurrent Malignant Mesothelioma
              • Recurrent Primary Peritoneal Carcinoma
              • Refractory Malignant Mesothelioma
              • Resectable Malignant Mesothelioma
              • Resectable Sarcoma
              Interventions
              • Drug: Cisplatin
              • Procedure: Cytoreductive Surgery
              • Drug: Doxorubicin
              • Drug: Hyperthermic Intraperitoneal Chemotherapy
              • Drug: Sodium Thiosulfate
              Facility
              • Mayo Clinic in Rochester, Rochester, Minnesota
              Clinical Trial for Pancreatic Cancer from NGM Biopharmaceuticals, Inc
              Location: New Haven, Connecticut (multiple locations)
              Call (855) 947-1097 to get help enrolling in this clinical trial
              Clinical Trial for Pancreatic Cancer from NGM Biopharmaceuticals, Inc

              Our Patient Advocates can help you connect with clinical trials

              Call (855) 947–1097 to get started

              Trial Name
              A Phase 1/1b Dose Escalation/Expansion Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

              Conditions
              • Non Small Cell Lung Cancer
              • Mesothelioma
              Interventions
              • Drug: NGM438
              Facility
              • Yale Cancer Center, New Haven, Connecticut
              • Henry Ford Health System, Detroit, Michigan
              • START Midwest, Grand Rapids, Michigan
              • Mount Sinai Hospital, New York, New York
              • MD Anderson, Houston, Texas
              Clinical Trial for Solid Tumor from IDEAYA Biosciences
              Location: Scottsdale, Arizona (multiple locations)
              Call (855) 947-1097 to get help enrolling in this clinical trial
              Clinical Trial for Solid Tumor from IDEAYA Biosciences

              Our Patient Advocates can help you connect with clinical trials

              Call (855) 947–1097 to get started

              Trial Name
              An Open Label, Phase 1, Treatment Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of IDE397 (MAT2A Inhibitor) In Adult Participants With Advanced Solid Tumors

              Conditions
                Interventions
                • Drug: IDE397
                Facility
                • Honor Health Research Institute, Scottsdale, Arizona
                • City of Hope, Duarte, California
                • Indiana University Health Hospital, Indianapolis, Indiana
                • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
                • Dana Farber Cancer Institute, Boston, Massachusetts
                • Columbia University Medical Center - Herbert Irving Pavilion, New York, New York
                • Weill Cornell Medical College, New York, New York
                • Stephenson Cancer Center, Oklahoma City, Oklahoma
                • The Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee
                • MD Anderson, Houston, Texas
                • Next Oncology, San Antonio, Texas
                Clinical Trial for Mesothelioma from Mayo Clinic
                Location: Rochester, Minnesota
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Mesothelioma from Mayo Clinic

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma

                Conditions
                • Mesothelioma
                • Solitary Fibrous Tumor of the Pleura
                Facility
                • Mayo Clinic in Rochester, Rochester, Minnesota
                Clinical Trial for Microsatellite High Cancers from M.D. Anderson Cancer Center
                Location: Houston, Texas
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Microsatellite High Cancers from M.D. Anderson Cancer Center

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

                Conditions
                • Peritoneal Mesothelioma
                • Pleural Mesothelioma
                • Small Cell Lung Cancer
                Interventions
                • Drug: XmAb20717
                Facility
                • M D Anderson Cancer Center, Houston, Texas
                Clinical Trial for Lung Adenocarcinoma from University of Pennsylvania
                Location: Philadelphia, Pennsylvania
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Lung Adenocarcinoma from University of Pennsylvania

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                Phase I Study of Human Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers

                Conditions
                • Lung Adenocarcinoma
                • Peritoneal Carcinoma
                • Mesotheliomas Pleural
                • Mesothelioma Peritoneum
                Interventions
                • Biological: huCART-meso cells
                Facility
                • University of Pennsylvania, Philadelphia, Pennsylvania
                Clinical Trial for Nasopharyngeal Carcinoma from Ascentage Pharma Group Inc.
                Location: Springdale, Arkansas
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Nasopharyngeal Carcinoma from Ascentage Pharma Group Inc.

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                A Phase I Study of Safety, Pharmacokinetic and Efficacy of Orally Administered APG-5918 in Patients With Advanced Solid Tumors or Hematologic Malignancies

                Conditions
                • Mesothelioma
                Interventions
                • Drug: APG-5918
                Facility
                • Highlands Oncology, Springdale, Arkansas
                Clinical Trial for Familial Cancer from National Institutes of Health Clinical Center (CC)
                Location: Bethesda, Maryland
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Familial Cancer from National Institutes of Health Clinical Center (CC)

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

                Conditions
                • Mesothelioma
                Facility
                • National Institutes of Health Clinical Center, Bethesda, Maryland
                Clinical Trial for Advanced Solid Tumors from PharmaMar
                Location: Boston, Massachusetts (multiple locations)
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Advanced Solid Tumors from PharmaMar

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Pretreated Patients With Selected Advanced Solid Tumors

                Conditions
                • Soft Tissue Sarcoma (Excluding GIST)
                • Mesothelioma
                Interventions
                • Drug: Lurbinectedin
                • Drug: Irinotecan
                Facility
                • Massachusetts General Hospital -, Boston, Massachusetts
                • Beth Israel Deaconess Medical Center, Boston, Massachusetts
                • The University of Texas MD Anderson Cancer Center, Houston, Texas
                Clinical Trial for Pancreatic Cancer from NGM Biopharmaceuticals, Inc
                Location: Gilbert, Arizona (multiple locations)
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Pancreatic Cancer from NGM Biopharmaceuticals, Inc

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                A Phase 1/1b Dose Escalation/Expansion Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

                Conditions
                • Non-small Cell Lung Cancer
                • Mesothelioma
                Interventions
                • Drug: NGM831
                Facility
                • NGM Clinical Study Site, Gilbert, Arizona
                • NGM Clinical Study Site, Los Angeles, California
                • NGM Clinical Study Site, Sarasota, Florida
                • NGM Clinical Study Site, Tampa, Florida
                • NGM Clinical Study Site, Grand Rapids, Michigan
                • NGM Clinical Study Site, New York, New York
                • NGM Clinical Study Site, Oklahoma City, Oklahoma
                • NGM Clinical Study Site, Austin, Texas
                • NGM Clinical Study Site, Houston, Texas
                Clinical Trial for Advanced Solid Tumor from Constellation Pharmaceuticals
                Location: Atlanta, Georgia (multiple locations)
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Advanced Solid Tumor from Constellation Pharmaceuticals

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                A Phase 1/2 Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas

                Conditions
                • Mesothelioma, Malignant
                Interventions
                • Drug: CPI-0209
                Facility
                • Emory University Hospital, Atlanta, Georgia
                • University of Chicago Medical Center, Chicago, Illinois
                • University of Maryland - Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland
                • Massachusetts General Hospital, Boston, Massachusetts
                • Dana Farber Cancer Institute, Boston, Massachusetts
                • University of Michigan, Ann Arbor, Michigan
                • START Midwest, Grand Rapids, Michigan
                • Hackensack University Medical Center, Hackensack, New Jersey
                • Montefiore Einstein Center for Cancer Care, Bronx, New York
                • NYU Langone Medical Center - Laura and Isaac Perlmutter Cancer Center, New York, New York
                • University of Cincinnati Medical Center, Cincinnati, Ohio
                • START San Antonio, San Antonio, Texas
                • University of Virginia Cancer Center, Charlottesville, Virginia
                • Swedish Cancer Institute, Seattle, Washington
                Clinical Trial for Pancreatic Cancer from University of Nebraska
                Location: Colorado Springs, Colorado (multiple locations)
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Pancreatic Cancer from University of Nebraska

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                Integrated Cancer Repository for Cancer Research

                Conditions
                • Lung Cancer
                • Peritoneal Surface Malignancies
                • Mesothelioma
                Facility
                • Penrose Cancer Center, Colorado Springs, Colorado
                • Porter Adventist Hospital, Denver, Colorado
                • Mercy Regional Medical Center, Durango, Colorado
                • St. Anthony Hospital, Lakewood, Colorado
                • Littleton Cancer Center, Littleton, Colorado
                • Longmont Cancer Center, Longmont, Colorado
                • Avista Cancer Center, Louisville, Colorado
                • Parker Adventist Hospital, Parker, Colorado
                • St. Mary Corwin Medical Center, Pueblo, Colorado
                • St. Anthony North Cancer Center, Westminster, Colorado
                • Florida Hospital Memorial Medical Center, Daytona Beach, Florida
                • Florida Hospital DeLand, DeLand, Florida
                • Florida Hospital FISH, Orange City, Florida
                • Florida Hospital Flagler, Palm Coast, Florida
                • Tallahassee Memorial Hospital, Tallahassee, Florida
                • Rush-Copley Cancer Care Center, Aurora, Illinois
                • Trinity Medical Center, Moline, Illinois
                • Rush-Copley Healthcare Center, Yorkville, Illinois
                • Parkview Research Center, Fort Wayne, Indiana
                • Community Health Network, Indianapolis, Indiana
                • Community Cancer Center South, Indianapolis, Indiana
                • Community Cancer Center North, Indianapolis, Indiana
                • Community Howard Regional Hospital, Kokomo, Indiana
                • Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa
                • Genesis Medical Center, Davenport, Iowa
                • Abben Cancer Center, Spencer, Iowa
                • Covenant Medical Center, Inc, Waterloo, Iowa
                • Saint Luke's Cancer Instititue - South, Overland Park, Kansas
                • Tulane University, New Orleans, Louisiana
                • Breast Care Specialists of Maine, Portland, Maine
                • Northwest Hospital, Randallstown, Maryland
                • William E Kahlert Regional Cancer Center, Westminster, Maryland
                • Holyoke Medical Center, Holyoke, Massachusetts
                • University of Michigan Health System, Ann Arbor, Michigan
                • Riverwood Healthcare Center, Aitkin, Minnesota
                • Essentia Health-St. Joseph's Medical Center, Brainerd, Minnesota
                • Essentia Health - Duluth Clinic, Duluth, Minnesota
                • St. Luke's Hospital of Duluth, Duluth, Minnesota
                • Lake Region Healthcare, Fergus Falls, Minnesota
                • Avera Cancer Institute- Marshall, Marshall, Minnesota
                • Mercy Hospital - Joplin, Joplin, Missouri
                • Saint Luke's Cancer Institute - East, Kansas City, Missouri
                • Saint Luke's Cancer Institute, Kansas City, Missouri
                • Saint Luke's Cancer Institute - Kansas City North, Kansas City, Missouri
                • Saint Luke's Cancer Institute - Liberty, Liberty, Missouri
                • Heartland Regional Medical Center dba Mosaic Life Care, Saint Joseph, Missouri
                • Bozeman Health Deaconess Hospital, Bozeman, Montana
                • Logan Health, Kalispell, Montana
                • Providence St. Patrick Hospital Montana Cancer Center, Missoula, Montana
                • Mary Lanning Healthcare/Morrison Cancer Center, Hastings, Nebraska
                • Faith Regional Health Services, Carson Cancer Center, Norfolk, Nebraska
                • Great Plains Regional Medical Center, North Platte, Nebraska
                • Avera St. Anthony's Hospital, O'Neill, Nebraska
                • Methodist Estabrook Cancer Center, Omaha, Nebraska
                • Nebraska Methodist Health System, Omaha, Nebraska
                • University of Nebraska Medical Center, Omaha, Nebraska
                • Regional West Health Services, Scottsbluff, Nebraska
                • C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls, New York
                • Faxton St. Luke's Healthcare/Mohawk Valley, Utica, New York
                • Cape Fear Valley Health System, Fayetteville, North Carolina
                • Essentia Health, Fargo, North Dakota
                • Trinity Hospital Cancer Care Center, Minot, North Dakota
                • Aultman Alliance Community Hospital, Alliance, Ohio
                • Aultman Hospital, Canton, Ohio
                • University of Pittsburgh, Pittsburgh, Pennsylvania
                • Avera Medical Group Oncology and Hematology Aberdeen, Aberdeen, South Dakota
                • Avera Cancer Institute, Mitchell, South Dakota
                • Avera Cancer Institute, Sioux Falls, South Dakota
                • Sanford Health, Sioux Falls, South Dakota
                • Avera Cancer Center Yankton, Yankton, South Dakota
                • Avera Sacred Heart Hospital, Yankton, South Dakota
                • Yankton Medical Clinic, Yankton, South Dakota
                • Rutland Regional Medical Center, Rutland, Vermont
                • Mary Washington Hospital, Fredericksburg, Virginia
                • Ascension St. Elizabeth Hospital, Appleton, Wisconsin
                • Wheaton Franciscan Healthcare - Elmbrook Memorial Hospital, Brookfield, Wisconsin
                • Wheaton Franciscan Healthcare - Reiman Cancer Care, Franklin, Wisconsin
                • Bellin Memorial Hospital, Green Bay, Wisconsin
                • Columbia St. Mary's, Mequon, Wisconsin
                • Columbia St. Mary's, Milwaukee, Wisconsin
                • Ascension Mercy Hospital, Oshkosh, Wisconsin
                • Wheaton Franciscan Healthcare - All Saints, Racine, Wisconsin
                • Wheaton Franciscan Healthcare - Wauwatosa Cancer Care, Wauwatosa, Wisconsin
                Clinical Trial for Advanced Solid Tumor from Incyte Corporation
                Location: Boston, Massachusetts (multiple locations)
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Advanced Solid Tumor from Incyte Corporation

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Select Advanced Solid Tumors

                Conditions
                • Small-cell Lung Cancer
                • Mesothelioma
                Interventions
                • Drug: INCB099280
                Facility
                • Dana Farber Cancer Institute, Boston, Massachusetts
                • Henry Ford Hospital, Detroit, Michigan
                • Upmc Cancercenter, Pittsburgh, Pennsylvania
                • Md Anderson Cancer Center, Houston, Texas
                • University of Washington, Seattle, Washington
                Clinical Trial for Metastatic Cancer from Symphogen A/S
                Location: Grand Rapids, Michigan (multiple locations)
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Metastatic Cancer from Symphogen A/S

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                A Phase 1, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of Sym024 (Anti-CD73) as Monotherapy and in Combination With Sym021 (Anti-PD-1) in Patients With Advanced Solid Tumor Malignancies

                Conditions
                • Metastatic Cancer
                Interventions
                • Drug: Sym024
                Facility
                • START Midwest, Grand Rapids, Michigan
                • MD Anderson Cancer Center, Houston, Texas
                • NEXT Oncology, San Antonio, Texas
                Clinical Trial for Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc.
                Location: Duarte, California (multiple locations)
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc.

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                A Phase 1a, Dose Escalation, Safety and Tolerability Study of NX-1607, a Casitas B-lineage Lymphoma Proto-oncogene (CBL-B) Inhibitor, in Adults With Advanced Malignancies, With Phase 1b Expansion in Select Tumor Types

                Conditions
                • Malignant Pleural Mesothelioma (MPM)
                Interventions
                • Drug: NX-1607
                Facility
                • City of Hope, Duarte, California
                • University of North Carolina, Chapel Hill, North Carolina
                • MD Anderson Cancer Center, Houston, Texas
                Clinical Trial for Thyroid from SOTIO Biotech
                Location: New Haven, Connecticut (multiple locations)
                Call (855) 947-1097 to get help enrolling in this clinical trial
                Clinical Trial for Thyroid from SOTIO Biotech

                Our Patient Advocates can help you connect with clinical trials

                Call (855) 947–1097 to get started

                Trial Name
                A Multicenter Open-label Phase 1/1b Study to Evaluate the Safety and Preliminary Efficacy of SO-C101 as Monotherapy and in Combination With Pembrolizumab in Patients With Selected Advanced/Metastatic Solid Tumors

                Conditions
                • Non Small Cell Lung Cancer
                • Small-cell Lung Cancer
                • Mesothelioma
                Interventions
                • Drug: SO-C101
                Facility
                • Yale Cancer Center, New Haven, Connecticut
                • University of Pittsburgh, Pittsburgh, Pennsylvania
                • MD Anderson Cancer Center, Houston, Texas
                of Don't see what you're looking for? Call (855) 947-1097 so one of our Patient Advocates can help you find the right clinical trial.

                What State Has the Most Mesothelioma Cases?

                California ranks first among states with the most mesothelioma cases. A total of 6,503 Californians were diagnosed with mesothelioma between 1999 and 2018, according to the Centers for Disease Control and Prevention (CDC).

                Mesothelioma Rates by State

                Some states have higher rates of mesothelioma because they have a long history of industries that heavily relied on asbestos, such as shipbuilding, mining, and manufacturing.

                According to CDC data, these 10 states have the highest incidence rates for mesothelioma:

                StateMesothelioma CasesPopulationIncidence Rate
                1. Maine51326,350,6901.5%
                2. Alaska12813,839,0161.4%
                3. New Jersey2,654174,234,0481.4%
                4. Delaware27217,554,4991.4%
                5. Washington1,799132,284,0231.3%
                6. Louisiana1,22890,660,6761.3%
                7. West Virginia61436,590,1721.3%
                8. Wyoming14710,870,0111.3%
                9. Pennsylvania4,040251,711,6171.3%
                10. Wisconsin1,581112,331,9091.3%

                Thankfully, there are experienced specialists in each of these states who can treat people diagnosed with mesothelioma and other asbestos-related diseases.

                Learn more about treatments, specialists, and help for asbestos exposure in our Free Mesothelioma Guide — shipped overnight to your door.

                Mesothelioma Guide Images
                Get Your Free 2023 Mesothelioma Guide
                • Top treatments & doctors
                • Financial assistance
                • Accessing VA benefits

                Get Your Free Guide

                Find Mesothelioma Treatment Near You Today

                Locating mesothelioma treatment near you is a crucial step you can take toward fighting this rare cancer. With advancements in mesothelioma research and treatment options, there is increasing hope for better survival outcomes and improved quality of life.

                Our highly trained Patient Advocates can help you connect with mesothelioma doctors and treatment centers in your state. We can also see if you qualify for financial assistance that can help pay for your cancer treatments.

                Find a mesothelioma specialist in your state to get started.

                Written by:

                Lead Editor

                Laura Wright is a journalist and content strategist with more than 15 years of professional experience. She attended college at the University of Florida, graduating magna cum laude with a bachelor’s degree in journalism in 2008. Her writing has been featured in The Gainesville Sun and other regional publications throughout Florida.

                References
                1. American Cancer Society. (2018, November 16). Chemotherapy for malignant mesothelioma. Retrieved May 10, 2023, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/chemotherapy.html

                2. American Cancer Society. (2018, November 16). Immunotherapy for malignant mesothelioma. Retrieved May 10, 2023, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/immunotherapy.html

                3. American Cancer Society. (2018, November 16). Radiation for malignant mesothelioma. Retrieved May 10, 2023, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/radiation.html

                4. American Cancer Society. (2018, November 16). Surgery for malignant mesothelioma. Retrieved May 10, 2023, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/surgery.html

                5. American Cancer Society. (2019, May 18). What’s New in Malignant Mesothelioma Research? Retrieved May 10, 2023, from https://www.cancer.org/cancer/malignant-mesothelioma/about/new-research.html

                6. Bou-Samra, P., et al. (2023). Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database. Cancer Medicine. Retrieved May 10, 2023, from https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.5915

                7. Cancer Therapy Advisor. (2017). Pleural plaques/Mesothelioma. Retrieved May 10, 2023, from https://www.cancertherapyadvisor.com/home/decision-support-in-medicine/hospital-medicine/pleural-plaques-mesothelioma/

                8. Centers for Disease Control and Prevention. (2023). United States and Puerto Rico Cancer Statistics, 1999-2018 Incidence Archive Request. Retrieved May 10, 2023, from https://wonder.cdc.gov/controller/datarequest/D172;jsessionid=DA3FC143B54F55C2AAA615EBC193?stage=results&action=sort&direction=MEASURE_DESCEND&measure=D172.M1

                9. MD Anderson Cancer Center. (2021, July 14). Atezolizumab and bevacizumab show meaningful responses for malignant peritoneal mesothelioma patients. Retrieved May 10, 2023 from https://www.mdanderson.org/newsroom/atezolizumab-and-bevacizumab-show-meaningful-responses-for-malignant-peritoneal-mesothelioma-patients.h00-159462423.html

                10. National Cancer Institute. (n.d.). Find a Cancer Center. Retrieved May 10, 2023, from https://www.cancer.gov/research/infrastructure/cancer-centers/find

                11. National Cancer Institute (2019, June 24). NCI-Designated Cancer Centers. Retrieved May 10, 2023, from https://www.cancer.gov/research/infrastructure/cancer-centers

                12. Rossini, M., et al. (2018). New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma. Frontiers in Oncology. Retrieved May 10, 2023, from https://www.frontiersin.org/articles/10.3389/fonc.2018.00091/full

                Speak to a Patient Advocate About Your Options

                If you or someone you love has been diagnosed with mesothelioma, there is hope. Contact us to learn more about mesothelioma and your treatment options.

                • Latest treatment information
                • Financial assistance for treatment
                • VA benefits help

                Submit your information and a Patient Advocate will call you right back!

                Complete the Form to Speak to a Patient Advocate

                Free Survivors Guide
                7 inspiring stories of hope & survival
                • Survivors who beat the odds
                • Tips for fighting mesothelioma
                • Navigating life after treatment
                Get Your Free Download

                “If I can help give even one person a small bit of hope, then this life of mine is worth something.”

                Alexis Kidd, Mesothelioma Survivor